InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Benevich Eric, Directeur Commercial. Officer active across 1 company, notably Neurocrine Biosciences INC. Aggregated, 25 reports have been published. Breakdown: 0 buy · 11 sells. Total volume traded: €2.7m. History available since 16 August 2021. The latest transaction was disclosed on 12 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Benevich Eric
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
2,005 shares0Common StockSEC:0001643653-26-000011:0
2,294 shares0Common StockSEC:0001643653-26-000008:0
12,830 shares@ US$35.990.0028% mcap22.5% of flowCommon StockSEC:0001643653-26-000005:0
5,970 shares@ US$151.73888.5% of flowCommon StockSEC:0001643653-25-000007:1
5,970 shares@ US$35.992.0% of flowCommon StockSEC:0001643653-25-000007:0
2,083 shares0Common StockSEC:0000914475-25-000057:0
1,860 shares0Common StockSEC:0000914475-25-000047:0
2,294 shares0Common StockSEC:0000914475-25-000021:0
7,231 shares@ US$81.496.0% of flowCommon StockSEC:0000914475-24-000111:0
5,479 shares@ US$79.024.3% of flowCommon StockSEC:0000914475-24-000096:0
53,143 shares@ US$43.2423.0% of flowCommon StockSEC:0000914475-24-000082:0
1,098 shares@ US$133.01491.5% of flowCommon StockSEC:0000914475-24-000068:0
1,280 shares@ US$142.11721.8% of flowCommon StockSEC:0000914475-24-000044:0
1,207 shares@ US$140.78441.7% of flowCommon StockSEC:0000914475-24-000023:0
1,600 shares@ US$107.39751.7% of flowCommon StockSEC:0001209191-23-047128:0
1,280 shares@ US$105.62561.4% of flowCommon StockSEC:0001209191-23-007907:0
1,207 shares@ US$109.95051.3% of flowCommon StockSEC:0001209191-23-006259:0
400 shares@ US$43.240.2% of flowCommon StockSEC:0001209191-23-002829:0
400 shares@ US$125.000.5% of flowCommon StockSEC:0001209191-23-002829:1
22,162 shares@ US$41.789.7% of flowCommon StockSEC:0001209191-22-059245:0
24,593 shares@ US$41.7811.1% of flowCommon StockSEC:0001209191-22-056437:0
400 shares@ US$41.780.2% of flowCommon StockSEC:0001209191-22-055817:0
4,960 shares@ US$110.82296.0% of flowCommon StockSEC:0001209191-22-054117:0
809 shares@ US$80.67870.0004% mcap3.2% of flowCommon StockSEC:0001209191-22-008204:0
5,628 shares@ US$89.62245.1% of flowCommon StockSEC:0001209191-21-052337:0
25 of 25 declarations
About Benevich Eric
BENEVICH ERIC is Directeur Commercial and Chief Commercial Officer at Neurocrine Biosciences INC (XNAS). He has 25 filings in total, and across the sampled recent filings, sell transactions total 2738782 EUR with no buys, over the period from 2021-08-18 to 2026-02-17. The modal transaction nature is Levée d'options.
